Richard Champlin
Professor of Medicine · University of Texas M D Anderson Cancer Center
Credentials: · · · · · · ·
History
- 1978–1980
UCLA Center for the Health Sciences
Research
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
New England Journal of Medicine · 2020 · 1,804 citations
Journal of Clinical Oncology · 1997 · 1,031 citations
Blood · 1997 · Last of 20 authors · 932 citations
348 papers
283 papers · 2 as a fellow
267 papers
256 papers
- SG
232 papers
228 papers
227 papers
- BA
181 papers
Grants
- 1994–2020
T32 Research Training in Academic Medical Oncology
National Cancer Institute · T32
Contact PI · $947K · University of Tx Md Anderson Can Ctr
- 2002–2017
Improving the Outcomes of Stem Cell Transplantation
National Heart, Lung, and Blood Institute · U10
Contact PI · $483.5K · University of Tx Md Anderson Can Ctr
- 1989–2016
National Cancer Institute · P01
Contact PI · $50M · University of Tx Md Anderson Can Ctr
- 1997–2016
National Cancer Institute · P01
Project lead · $2.4M · University of Tx Md Anderson Can Ctr
Clinical trials
- 2019–2027
Principal investigator · Active not recruiting · Phase 1, Phase 2
M.D. Anderson Cancer Center
- 2015–2022
Principal investigator · Completed · Phase 2
Arog Pharmaceuticals, Inc.
- 2015–2020
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
Principal investigator · Completed · Phase 1
M.D. Anderson Cancer Center
- 2013–2017
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
Principal investigator · Terminated · Phase 1, Phase 2
M.D. Anderson Cancer Center